FDA Approves New HIV Drug

by Sheela Philomena on  May 21, 2011 at 9:06 AM Drug News
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration approved a new HIV drug, Edurant. This medication fights HIV in combination with other antiretrovirals.
 FDA Approves New HIV Drug
FDA Approves New HIV Drug

Made by the New Jersey based Tibotec Therapeutics, Edurant helps block the virus from replicating and is part of a class of drugs known as non-nucleoside reverse transcriptase inhibitor.

The pill is to be taken once daily with food, the FDA said.

"Patients may respond differently to various HIV drugs or experience varied side effects," said Edward Cox, director of the office of antimicrobial products in the FDA's Center for Drug Evaluation and Research.

"FDA's approval of Edurant provides an additional treatment option for patients who are starting HIV therapy."

The approval followed phase II and II trials that showed that patients who had not received previous therapy saw an 83 percent lower viral load after they took Edurant along with other antiretroviral drugs.

Side effects included depression, insomnia, headache and rash.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive